Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11026 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Alexandropoulou I., Romanidou G., Konstasntinidis T. G., Terzi E., Saridou S., et al. (2011).  Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used.. Int J Gen Med. 4, 15-9.
Zarogoulidis, P., Chatzaki E., Hohenforst-Schmidt W., Goldberg E. P., Galaktidou G., Kontakiotis T., et al. (2012).  Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.. Cancer Gene Ther. 19(9), 593-600.
Zarogoulidis, P., Sapalidis K., Kosmidis C., Tsakiridis K., Huang H., Bai C., et al. (2020).  Stents for small airways: current practice.. Expert Rev Respir Med. 14(10), 969-972.
Zarogoulidis, P., Kioumis I., Tsiouda T., Pezirkianidis N., Ritzoulis C., Huang H., et al. (2014).  A 3D Polymer Model for Future Nutrition Design Novel Nutrition Approach for Cystic Fibrosis, Ulcerative Colitis and Crohn's Disease.. J Nanomedine Biotherapeutic Discov. 4(2), 128.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Boutsikou E., Machairiotis N., Tsakiridis K., et al. (2013).  Treatment of non-small cell lung cancer (NSCLC).. J Thorac Dis. 5 Suppl 4, S389-96.
Zarogoulidis, P., Yarmus L., & Zarogoulidis K. (2013).  New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.. Ther Deliv. 4(10), 1221-3.
Zarogoulidis, K., Boutsikou E., Zarogoulidis P., Darwiche K., Freitag L., Porpodis K., et al. (2013).  The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis.. Onco Targets Ther. 6, 1493-500.
Zarogoulidis, P., Chinelis P., Athanasiadou A., Tsiouda T., Trakada G., Kallianos A., et al. (2017).  Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases.. Respir Med Case Rep. 22, 101-105.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sapalidis K., Kosmidis C., Tryfon S., et al. (2020).  Vapor for lung volume reduction; pros and cons.. Expert Rev Respir Med. 14(12), 1189-1195.
Zarogoulidis, P., Trakada G., & Zarogoulidis K. (2013).  A chrono-target chemotherapy treatment model for lung cancer treatment.. Ther Deliv. 4(1), 5-8.
Zarogoulidis, P., Terzi E., Kouliatsis G., Androuli S., Kontakiotis T., Zaramboucas T., et al. (2011).  Orbital metastases as the first manifestation of lung adenocarcinoma.. Case Rep Ophthalmol. 2(1), 34-8.
Zarogoulidis, P., Kosmidis C., Fyntanidou V., Barmpas A., Koulouris C., Aidoni Z., et al. (2019).  Elastography during convex-probe (endobronchial ultrasound) for optimal biopsy sample and gene identification in non-small-cell lung cancer.. Biomark Med. 13(14), 1153-1156.
Zarogoulidis, P., Petridis D., Ritzoulis C., Li Q., Huang H., Ning Y., et al. (2013).  Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.. Int J Pharm. 458(1), 39-47.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Sardeli C., Man Y-G., et al. (2018).  Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: tumor mutation burden and PD-L1 ≥50.. Transl Lung Cancer Res. 7(Suppl 1), S28-S30.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.
Zarogoulidis, P., Kioumis I., Ritzoulis C., Petridis D., Darwiche K., Porpodis K., et al. (2013).  New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.. Int J Pharm. 455(1-2), 182-8.
Zarogoulidis, P., Kouliatsis G., Papanas N., Spyratos D., Constantinidis T. C., Kouroumichakis I., et al. (2011).  Long-term respiratory follow-up of H1N1 infection.. Virol J. 8, 319.
Zarogoulidis, P., Katsikogianni F., Tsiouda T., Sakkas A., Katsikogiannis N., & Zarogoulidis K. (2014).  Interleukin-8 and interleukin-17 for cancer.. Cancer Invest. 32(5), 197-205.
Zarogoulidis, P., Christakidis V., Petridis D., Sapalidis K., Kosmidis C., Vagionas A., et al. (2020).  Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.. Expert Rev Respir Med.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Tsakiridis K., Machairiotis N., Kougioumtzi I., et al. (2013).  Malignant pleural effusion and algorithm management.. J Thorac Dis. 5 Suppl 4, S413-9.
Zarogoulidis, P., Kioumis I., Porpodis K., Spyratos D., Tsakiridis K., Huang H., et al. (2013).  Clinical experimentation with aerosol antibiotics: current and future methods of administration.. Drug Des Devel Ther. 7, 1115-34.
Zarogoulidis, P., Orfanidis M., Constadinidis T. C., Eleutheriadou E., Kontakiotis T., Kerenidi T., et al. (2011).  A 26-year-old male with mesothelioma due to asbestos exposure.. Case Rep Med. 2011, 951732.
Zarogoulidis, P., Kioumis I., Papanas N., Manika K., Kontakiotis T., Papagianis A., et al. (2012).  The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature.. J Chemother. 24(3), 173-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.